Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

Completed · Phase 3

Conditions studied: Familial Hypercholesterolemia

In brief

This was a long term follow on study to assess the continued long term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia.

Key facts

Study ID

NCT00943306

Run by

Aegerion Pharmaceuticals, Inc.

People needed

19

Starts

2009-10-29

Expected to finish

2014-12-01

Last updated by the study team

2018-06-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completed UP1002 or 733-005.
• Willing and able to provide consent and comply with the requirements of the study protocol.

You may not qualify if…

• Met any of the stopping rules for study discontinuation at the final visit of study UP1002 or 733-005.

Where it is running

• Cedars-Sinai Medical Center — Los Angeles, California, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Robarts Research Institute — London, Ontario, Canada
• Lipid Clinic and University of Montreal Community Genomic Medicine Center — Chicoutimi, Quebec, Canada
• Medicina Interna Universitaria — Ferrara, Sicily, Italy
• Dipartimento di Medicina Clinica e Delle Patologie Emergenti — Palermo, Sicily, Italy
• Centro Universitario Dislipidemie — Milan, Italy
• DAI Ematologia, Oncologia, Anatomia Patologica e Medicina — Roma, Italy
• Cardiology Research — Bloemfontein, South Africa
• University of Capetown — Cape Town, South Africa

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.